News About: R&D
The number of generics per a bioequivalence test was 4 products… the number of the tests went also up
As the regulation to restrict the number of companies participating in a joint or consigned bioequivalence test to 2 companies was abolished, the number of consigned bioequivalence tests increased.
As the result of a...
The Chong Kun Dang’s extremely obese treatment has been confirmed effectiveness through clinical trials in the U.S.Chong Kun Dang (CEO Jung-woo Kim)confirmed effectiveness of the extremely obese treatment ‘CKD-732’, which has recently got on a Phase 3 clinical trialfor the Prader-Willi Syndr...
|
.jpg)
GSK and Lilly will launch diabetes drugs to inject once a week within this year
The two new diabetes drugs, that need to be administered once a week, will enter the Korean market.
According to the industry concerned on the 8th, GSK and Lilly are working to acquire domestic approvals for respecti...
SK Chemical attracted R&D funds from the Bill & Melinda Gates Foundation for vaccine studies
In order to conduct clinical research and development fora newly co-developingtyphoid vaccine, SK Chemical and the International Vaccine Institute (IVI) announced that they were supported with $ 4.9 million (KRW...
Sales rights of the film-type ‘Cialis’ developed by a medium-sized company
A film-type medicine, ‘Cialis’ made by a mid-sized pharmaceutical company, acquired the sale rights for the second time in Korea.
While Cialis is on a table to be negotiated with global enterprises for its launch, th...
It is expected to see Korean Companies to Have Solid Competitiveness on Development of Biosimilar Antibodies
While development of Biosimilar antibodies, a generic drug of the original biomedicine, is getting intensified, the Korean companies are expected to have solid competitiveness.
According to the data about the curren...
Celltrion received approval of Phase 3 clinical trial pla of 'CT-P10'
On June 29, Ministry of Food and Drug Safety approved Phase 3 clinical trial pla of 'CT-P10' from Celltrion. 'CT-P10' is a biosimilar product of MabThera (ingredient name: rituximab) which is for the treatment of rheu...
Treatment choices for patients with rheumatoid arthritis is expected to widen even more
Rheumatoid arthritis treatment options are evolving, so patients have a much wider choice.
The conventional treatment of rheumatoid arthritis includes TNF-alpha inhibitor, Humira (adalimumab) of Abbvie. Another TNF-a...
Kaelgemvax received European patent of malaria vaccine
Domestic biotech company Kaelgemvax, announced that they received European patent of malaria vaccine. This patent will be notified on June 4, 2014 to the European Patent Office (EPO). (Patent Number: EP1, 569,950)
Th...
Donga ST announced that superbacteria target antibiotics 'Tedizolid’ got approval of U.S. FDA Anti -Infective Drugs Advisory Committee
On Apr 1, Donga ST announced that superbacteria target antibiotics 'Tedizolid (brand name SIVEXTRO ™) of which they exported techniques to Trius Therapeutics, got approval of U.S. FDA Anti -Infective Drugs Advisory Co...
